Literature DB >> 11296310

Prefrontal-subcortical and limbic circuit mediation of major depressive disorder.

A L Brody1, M W Barsom, R G Bota, S Saxena.   

Abstract

Substantial progress has been made in elucidating the pathophysiology of major depressive disorder (MDD) using functional and structural brain imaging. In functional imaging studies comparing MDD subjects to normal controls at baseline, dorsolateral prefrontal cortex (DLPFC) activity has been found to be decreased and ventrolateral prefrontal cortex (VLPFC) activity has been found to be increased in MDD. Other regions found abnormal in baseline studies include the anterior cingulate gyrus (AC), temporal lobe, and basal ganglia. Studies examining mood state change (using sleep deprivation, sadness-induction, and tryptophan depletion) and changes from pre- to posttreatment have generally shown improvement of these abnormalities with improved MDD symptoms and worsening of these abnormalities with worsening symptoms. In structural imaging studies, decreased frontal lobe, hippocampal, and basal ganglia volumes are the most commonly reported findings. Several associations can be made between clinical features of MDD and brain function: (1) active sad thoughts/sadness with both decreased DLPFC and dorsal AC activity and increased VLPFC and ventral AC activity (2) psychomotor retardation with decreased left prefrontal activity (3) anxiety with increased left AC activity (4) impaired episodic memory with left prefrontal and medial temporal dysfunction and (5) impaired sustained attention with right prefrontal and parietal dysfunction. Copyright 2001 Copyright by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11296310     DOI: 10.1053/scnp.2001.21837

Source DB:  PubMed          Journal:  Semin Clin Neuropsychiatry        ISSN: 1084-3612


  40 in total

1.  Repeated stress causes cognitive impairment by suppressing glutamate receptor expression and function in prefrontal cortex.

Authors:  Eunice Y Yuen; Jing Wei; Wenhua Liu; Ping Zhong; Xiangning Li; Zhen Yan
Journal:  Neuron       Date:  2012-03-08       Impact factor: 17.173

2.  Regulation of emotional responses elicited by threat-related stimuli.

Authors:  Falk Eippert; Ralf Veit; Nikolaus Weiskopf; Michael Erb; Niels Birbaumer; Silke Anders
Journal:  Hum Brain Mapp       Date:  2007-05       Impact factor: 5.038

Review 3.  Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits.

Authors:  J D Salamone; M Correa; A Farrar; S M Mingote
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

4.  Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment.

Authors:  Matthew N Hill; Erica J Carrier; Ryan J McLaughlin; Anna C Morrish; Sarah E Meier; Cecilia J Hillard; Boris B Gorzalka
Journal:  J Neurochem       Date:  2008-07-15       Impact factor: 5.372

5.  Religion, evolution, and mental health: attachment theory and ETAS theory.

Authors:  Kevin J Flannelly; Kathleen Galek
Journal:  J Relig Health       Date:  2009-03-17

Review 6.  Impaired emotional learning and involvement of the corticotropin-releasing factor signaling system in patients with irritable bowel syndrome.

Authors:  Jennifer S Labus; Catherine S Hubbard; Joshua Bueller; Bahar Ebrat; Kirsten Tillisch; Michelle Chen; Jean Stains; George E Dukes; Dennis L Kelleher; Bruce D Naliboff; Michael Fanselow; Emeran A Mayer
Journal:  Gastroenterology       Date:  2013-08-14       Impact factor: 22.682

Review 7.  Psychomotor retardation in depression: biological underpinnings, measurement, and treatment.

Authors:  Jeylan S Buyukdura; Shawn M McClintock; Paul E Croarkin
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-10-31       Impact factor: 5.067

8.  Serotonin-2C and -2a receptor co-expression on cells in the rat medial prefrontal cortex.

Authors:  C Nocjar; K D Alex; A Sonneborn; A I Abbas; B L Roth; E A Pehek
Journal:  Neuroscience       Date:  2015-03-27       Impact factor: 3.590

9.  Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies.

Authors:  P Cédric M P Koolschijn; Neeltje E M van Haren; Gerty J L M Lensvelt-Mulders; Hilleke E Hulshoff Pol; René S Kahn
Journal:  Hum Brain Mapp       Date:  2009-11       Impact factor: 5.038

10.  Treatment with selective serotonin reuptake inhibitors and mirtapazine results in differential brain activation by visual erotic stimuli in patients with major depressive disorder.

Authors:  Won Kim; Bo-Ra Jin; Wan-Seok Yang; Kyuong-Uk Lee; Ra-Hyung Juh; Kook-Jin Ahn; Yong-An Chung; Jeong-Ho Chae
Journal:  Psychiatry Investig       Date:  2009-06-30       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.